federal_register: 2013-26549

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2013-26549 Draft Guidance for Industry on Pulmonary Tuberculosis: Developing Drugs for Treatment; Availability Notice The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Pulmonary Tuberculosis: Developing Drugs for Treatment." The purpose of the draft guidance is to assist sponsors in the development of antimycobacterial drugs for the treatment of pulmonary tuberculosis. This guidance applies to the development of a single investigational drug as well as development of two or more unmarketed investigational drugs for use in combination. 2013-11-06 2013 11 https://www.federalregister.gov/documents/2013/11/06/2013-26549/draft-guidance-for-industry-on-pulmonary-tuberculosis-developing-drugs-for-treatment-availability https://www.govinfo.gov/content/pkg/FR-2013-11-06/pdf/2013-26549.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Pulmonary Tuberculosis: Developing Drugs for Treatment." The purpose of the draft guidance is to assist sponsors in the development of...  

Links from other tables